Passenger leukocytes and microchimerism: what role in tolerance induction?
暂无分享,去创建一个
[1] A. Mellor,et al. Differential Susceptibility of Heart, Skin, and Islet Allografts to T Cell-Mediated Rejection1 , 2001, The Journal of Immunology.
[2] Fadi G Lakkis,et al. Immunologic ‘ignorance’ of vascularized organ transplants in the absence of secondary lymphoid tissue , 2000, Nature Medicine.
[3] V. Hadjianastassiou,et al. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection. , 2000, Transplantation.
[4] A. Sheil,et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. , 1999, Transplantation.
[5] A. Deiwick,et al. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat , 1999, Nature Medicine.
[6] K. Wood,et al. T-cell activation, proliferation, and memory after cardiac transplantation in vivo. , 1999, Annals of surgery.
[7] S. Brouard,et al. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. , 1998, Blood.
[8] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[9] B. Nordlinger,et al. Administration of exogenous interleukin-2 abrogates spontaneous rat liver allograft acceptance but does not affect long-term established graft survival. , 1997, Transplantation.
[10] C. Larsen,et al. Microchimerism and rejection in clinical transplantation , 1997, The Lancet.
[11] M. W. Flye,et al. Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation. , 1997, Transplantation.
[12] R. Bolman,et al. Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function. , 1996, Transplantation.
[13] D. Sachs,et al. Chimerism and transplantation tolerance: cause and effect. , 1996, Immunology today.
[14] K. Wood,et al. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. , 1996, Transplantation.
[15] A. Sheil,et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. , 1996, Journal of immunology.
[16] K. Wood,et al. Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. , 1995, Transplantation.
[17] J. Bradley,et al. ANTI‐CD45 MONOCLONAL ANTIBODY PERFUSION OF HUMAN RENAL ALLOGRAFTS PRIOR TO TRANSPLANTATION A SAFETY AND IMMUNOHISTOLOGICAL STUDY , 1995, Transplantation.
[18] R. Calne,et al. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats , 1995, Nature Medicine.
[19] S. Cobbold,et al. Mechanisms in CD4 antibody‐mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells , 1994, European journal of immunology.
[20] M. Karck,et al. Patterns of donor-type microchimerism after heart transplantation , 1994, The Lancet.
[21] T. Starzl,et al. Murine liver allograft transplantation: Tolerance and donor cell chimerism , 1994, Hepatology.
[22] H. Schlitt,et al. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. , 1994, The New England journal of medicine.
[23] T. Starzl,et al. CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION , 1993, Transplantation.
[24] C. Ricordi,et al. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. , 1993, Trends in pharmacological sciences.
[25] T. Starzl,et al. Systemic chimerism in human female recipients of male livers , 1992, The Lancet.
[26] M. Dallman,et al. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway , 1991, The Journal of experimental medicine.
[27] P. Morris,et al. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection , 1990, The Journal of experimental medicine.
[28] K. Wood,et al. Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. , 1985, Transplantation.
[29] F. Zimmermann,et al. ORTHOTOPIC LIVER ALLOGRAFTS IN THE RAT: THE INFLUENCE OF STRAIN COMBINATION ON THE FATE OF THE GRAFT , 1984, Transplantation.
[30] R. Lechler,et al. Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient , 1982, The Journal of experimental medicine.
[31] R. Lechler,et al. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells , 1982, The Journal of experimental medicine.
[32] J. Fabre,et al. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain , 1981, The Journal of experimental medicine.
[33] K. Lafferty,et al. Thyroid allograft immunogenicity is reduced after a period in organ culture. , 1975, Science.
[34] P. Morris,et al. THE EFFECT OF DONOR STRAIN BLOOD PRETREATMENT ON RENAL ALLOGRAFT REJECTION IN RATS , 1972, Transplantation.
[35] R. Binns,et al. Induction of Immunological Tolerance by Porcine Liver Allografts , 1969, Nature.